- Home
- CERT
CERT
Certara Inc.
as 02-21-2025 4:00pm EST
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Upcoming Earnings Alert:
Get ready for potential market movements as Certara Inc. CERT prepares to release earnings report on 26 Feb 2025.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | RADNOR |
| Market Cap: | 2.3B | IPO Year: | 2020 |
| Target Price: | $15.92 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.41 - $19.87 | Next Earning Date: | 02-26-2025 |
| Revenue: | $372,797,000 | Revenue Growth: | 5.62% |
| Revenue Growth (this year): | 10.48% | Revenue Growth (next year): | 9.94% |
Latest Certara Inc. News
CERT Breaking Stock News: Dive into CERT Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
CERT: What does Argus have to say about CERT?
Insider Monkey
8 days ago
Certara, Inc. (CERT): Among the Health Information Services Stocks Outpacing the Market in 2025
Argus Research
17 days ago
CERT: What does Argus have to say about CERT?
Zacks
18 days ago
Has BioRad Laboratories (BIO) Outpaced Other Medical Stocks This Year?
GlobeNewswire
24 days ago
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
Argus Research
24 days ago
CERT: Raising target price to $11.00
Insider Monkey
a month ago
Certara Inc. (CERT): Accelerating Drug Development with AI Amid Leerink’s Target Price Boost to $13
Simply Wall St.
a month ago
Exploring High Growth Tech Stocks in January 2025
Compare CERT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CERT Certara Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.